Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group

Background: Hemodynamic support with Impella (Abiomed Inc., Danvers, MA) devices is becoming a more prevalent treatment option for patients with cardiogenic shock (CS) undergoing percutaneous coronary intervention (PCI). There exists only limited published data regarding outcome differences between...

Full description

Bibliographic Details
Main Authors: Rajkumar Doshi, Krunalkumar Patel, Dean Decter, Rajiv Jauhar, Perwaiz Meraj
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Indian Heart Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483218300798
id doaj-480df30e40bb4c62b656f3880bdba974
record_format Article
spelling doaj-480df30e40bb4c62b656f3880bdba9742020-11-24T23:13:09ZengElsevierIndian Heart Journal0019-48322018-07-0170S90S95Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working GroupRajkumar Doshi0Krunalkumar Patel1Dean Decter2Rajiv Jauhar3Perwaiz Meraj4Corresponding author at: Department of Cardiology, North Shore University Hospital, 300 Community Dr, Manhasset, NY 11030, United States.; Department of Cardiology, North Shore University Hospital, Northwell Health, Manhasset, NY, United StatesDepartment of Cardiology, North Shore University Hospital, Northwell Health, Manhasset, NY, United StatesDepartment of Cardiology, North Shore University Hospital, Northwell Health, Manhasset, NY, United StatesDepartment of Cardiology, North Shore University Hospital, Northwell Health, Manhasset, NY, United StatesDepartment of Cardiology, North Shore University Hospital, Northwell Health, Manhasset, NY, United StatesBackground: Hemodynamic support with Impella (Abiomed Inc., Danvers, MA) devices is becoming a more prevalent treatment option for patients with cardiogenic shock (CS) undergoing percutaneous coronary intervention (PCI). There exists only limited published data regarding outcome differences between male and female patients. Therefore, the objective of this paper is to analyze these gender differences between short-term survival and in-hospital outcomes in those undergoing PCI with CS. Methods: Between January 2011 and July 2016, patients undergoing PCI with simultaneous use of Impella were identified. Only patients presenting with CS were included in the analysis. All-cause in-hospital mortality was the primary outcome. Using SAS 9.4 for propensity score matching, additional secondary outcomes were also compared. Results: The primary outcome was comparable between males and females (39.5% vs. 26.3%, p = 0.33) in CS patients. Secondary outcomes were also comparable and included: myocardial infarction, stroke, CS, heart failure, dialysis requirement, bleeding within 72 h, blood transfusion, dysrhythmia, composite of all complications, major adverse cardiac events. Survival at 30 days was equal in both groups. A reduced mortality in males was noted for pre-PCI initiation of Impella. Additionally, both genders who received pre-PCI Impella support, experienced a significant reduction in inotrope use. Conclusions: Despite the small number of cohorts, this study did not reveal any significant differences among gender with the use of percutaneous left ventricular assist devices for PCI in patients with acute myocardial infarction complicated by CS. However, initiation of Impella prior to PCI may be associated with improved mortality and morbidity in both genders. Keywords: Mechanical circulatory device, Cardiogenic shock, High-risk PCI, Genderhttp://www.sciencedirect.com/science/article/pii/S0019483218300798
collection DOAJ
language English
format Article
sources DOAJ
author Rajkumar Doshi
Krunalkumar Patel
Dean Decter
Rajiv Jauhar
Perwaiz Meraj
spellingShingle Rajkumar Doshi
Krunalkumar Patel
Dean Decter
Rajiv Jauhar
Perwaiz Meraj
Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group
Indian Heart Journal
author_facet Rajkumar Doshi
Krunalkumar Patel
Dean Decter
Rajiv Jauhar
Perwaiz Meraj
author_sort Rajkumar Doshi
title Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group
title_short Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group
title_full Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group
title_fullStr Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group
title_full_unstemmed Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group
title_sort gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: from pvad working group
publisher Elsevier
series Indian Heart Journal
issn 0019-4832
publishDate 2018-07-01
description Background: Hemodynamic support with Impella (Abiomed Inc., Danvers, MA) devices is becoming a more prevalent treatment option for patients with cardiogenic shock (CS) undergoing percutaneous coronary intervention (PCI). There exists only limited published data regarding outcome differences between male and female patients. Therefore, the objective of this paper is to analyze these gender differences between short-term survival and in-hospital outcomes in those undergoing PCI with CS. Methods: Between January 2011 and July 2016, patients undergoing PCI with simultaneous use of Impella were identified. Only patients presenting with CS were included in the analysis. All-cause in-hospital mortality was the primary outcome. Using SAS 9.4 for propensity score matching, additional secondary outcomes were also compared. Results: The primary outcome was comparable between males and females (39.5% vs. 26.3%, p = 0.33) in CS patients. Secondary outcomes were also comparable and included: myocardial infarction, stroke, CS, heart failure, dialysis requirement, bleeding within 72 h, blood transfusion, dysrhythmia, composite of all complications, major adverse cardiac events. Survival at 30 days was equal in both groups. A reduced mortality in males was noted for pre-PCI initiation of Impella. Additionally, both genders who received pre-PCI Impella support, experienced a significant reduction in inotrope use. Conclusions: Despite the small number of cohorts, this study did not reveal any significant differences among gender with the use of percutaneous left ventricular assist devices for PCI in patients with acute myocardial infarction complicated by CS. However, initiation of Impella prior to PCI may be associated with improved mortality and morbidity in both genders. Keywords: Mechanical circulatory device, Cardiogenic shock, High-risk PCI, Gender
url http://www.sciencedirect.com/science/article/pii/S0019483218300798
work_keys_str_mv AT rajkumardoshi genderdisparitieswiththeuseofpercutaneousleftventricularassistdeviceinpatientsundergoingpercutaneouscoronaryinterventioncomplicatedbycardiogenicshockfrompvadworkinggroup
AT krunalkumarpatel genderdisparitieswiththeuseofpercutaneousleftventricularassistdeviceinpatientsundergoingpercutaneouscoronaryinterventioncomplicatedbycardiogenicshockfrompvadworkinggroup
AT deandecter genderdisparitieswiththeuseofpercutaneousleftventricularassistdeviceinpatientsundergoingpercutaneouscoronaryinterventioncomplicatedbycardiogenicshockfrompvadworkinggroup
AT rajivjauhar genderdisparitieswiththeuseofpercutaneousleftventricularassistdeviceinpatientsundergoingpercutaneouscoronaryinterventioncomplicatedbycardiogenicshockfrompvadworkinggroup
AT perwaizmeraj genderdisparitieswiththeuseofpercutaneousleftventricularassistdeviceinpatientsundergoingpercutaneouscoronaryinterventioncomplicatedbycardiogenicshockfrompvadworkinggroup
_version_ 1725599013235851264